Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
While research is continuing, investigators have explored how the peptide may influence tissue repair, blood vessel formation, inflammation, and cellular signaling involved in recovery
Unlike earlier generation mono-agonists (targeting only GLP-1) or dual-agonists (targeting GLP-1 and GIP), Retatrutide exhibits high affinity for three distinct receptor sites: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon (GCG) receptor
Chuansangeam M, Phadungsaksawasdi P, Park HJ, Yang YH
Lillys triple-agonist retatrutide delivered significant average weight loss in phase 2 study
Theoretically, 2.5 mg of semaglutide would equal approximately: 368 units at 0.68 mg/mL concentration (2.5 mg 0.68 mg/mL 100) 187 units at 1.34 mg/mL concentration (2.5 mg 1.34 mg/mL 100) 93 units at 2.68 mg/mL concentration (2.5 mg 2.68 mg/mL 100) However, these calculations are purely theoretical
